“ROLE OF GLP-1 AGONISTS IN THE TREATMENT OF OBESITY-RELATED GASTROINTESTINAL DISORDERS”. 2025. The Research of Medical Science Review 3 (4): 1205-14. https://medicalsciencereview.com/index.php/Journal/article/view/1966.